The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

The writer of Back To The Future, Bob Gale, has given a blunt reaction to the idea of there ever being a fourth film.

Gain's lead program in Parkinson's disease has been awarded funding support from The Michael J. Fox Foundation for ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Taryn Robertson, a professor at Randolph College, is currently fundraising and training to run a marathon for her father who ...

Michael J. Fox might have a wholesome reputation these days, but he and a bunch of his celebrity friends once got busted by ...

A new report sheds a light on the unique challenges faced by family caregivers who care for loved ones with Parkinson’s disease (PD).